Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
24.69
+0.78 (3.26%)
At close: Jul 10, 2026

SHA:688443 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,0539,9889,20014,649--
Market Cap Growth
-17.29%8.57%-37.20%---
Enterprise Value
8,0988,7207,40512,246--
Last Close Price
24.6927.2425.0939.95--
PS Ratio
32.5943.29305.7012091.50--
PB Ratio
6.316.304.335.26--
P/TBV Ratio
6.506.484.425.35--
EV/Sales Ratio
29.1537.79246.0410108.38--
Debt / Equity Ratio
0.830.670.390.2326.891.83
Net Debt / Equity Ratio
-0.66-0.73-0.76-0.8217.030.42
Net Debt / EBITDA Ratio
1.732.202.063.05-0.87-0.48
Net Debt / FCF Ratio
1.912.732.604.86-1.53-0.37
Asset Turnover
0.090.080.010.0000.05
Inventory Turnover
0.280.230.11-0.040.80
Quick Ratio
4.354.7414.1221.332.275.15
Current Ratio
4.785.1715.0522.153.166.15
Return on Equity (ROE)
-32.85%-28.87%-32.47%-56.97%-337.99%-
Return on Assets (ROA)
-12.52%-11.87%-15.62%-21.82%-38.85%-25.14%
Return on Capital Employed (ROCE)
-24.60%-23.10%-28.30%-23.00%-73.10%-32.90%
Earnings Yield
-6.23%-5.36%-8.67%-5.47%--
FCF Yield
-5.53%-4.24%-6.75%-3.20%--
Buyback Yield / Dilution
0.37%0.14%-14.63%-16.79%0.32%-